Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Immunosenescence: the role of age in multiple sclerosis.
Neurologia (Engl Ed). 2023 May;38(4):284-290. doi: 10.1016/j.nrleng.2020.05.023. Epub 2022 Mar 5.
Neurologia (Engl Ed). 2023.
PMID: 35260362
Free article.
Review.
Thymic involution is the most noteworthy characteristic of this phenomenon. This process leads to a reduction in the number of virgin T cells. Other effects include an inverted CD4+/CD8+ cell ratio, severe alterations in NK cell functioning, and reduced tissue repair capac …
Thymic involution is the most noteworthy characteristic of this phenomenon. This process leads to a reduction in the number of virgin T …
Immunosenescence: the role of age in multiple sclerosis.
Ostolaza Ibáñez A, Corroza Laviñeta J, Ayuso Blanco T.
Ostolaza Ibáñez A, et al. Among authors: ayuso blanco t.
Neurologia (Engl Ed). 2020 Sep 19:S0213-4853(20)30226-7. doi: 10.1016/j.nrl.2020.05.016. Online ahead of print.
Neurologia (Engl Ed). 2020.
PMID: 32962809
Free article.
Review.
English, Spanish.
Thymic involution is the most noteworthy characteristic of this phenomenon. This process leads to a reduction in the number of virgin T cells. Other effects include an inverted CD4 + /CD8 + cell ratio, severe alterations in NK cell functioning, and reduced tissue repair ca …
Thymic involution is the most noteworthy characteristic of this phenomenon. This process leads to a reduction in the number of virgin T …
Item in Clipboard
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.
Arrambide G, Llaneza-González MÁ, Costa-Frossard França L, Meca-Lallana V, Díaz EF, Moreno-Torres I, García-Domínguez JM, Ortega-Suero G, Ayuso-Peralta L, Gómez-Moreno M, Sotoca-Fernández JJ, Caminero-Rodríguez AB, Rodríguez de Antonio LA, Corujo-Suárez M, Otano-Martínez MA, Pérez-Miralles FC, Reyes-Garrido V, Ayuso-Blanco T, Balseiro-Gómez JJ, Muñoz-Pasadas M, Pérez-Molina I, Arnal-García C, Domingo-Santos Á, Guijarro-Castro C, Íñiguez-Martínez C, Téllez Lara N, Castellanos-Pinedo F, Castillo-Triviño T, Cerdán-Santacruz DM, Pérez-Sempere Á, Torres BS, Álvarez de Arcaya A, Costa-Arpín E, Durán-Ferreras E, Fragoso-Martínez M, González-Platas M, Landete Pascual L, Millán-Pascual J, Oreja-Guevara C, Meca-Lallana JE.
Arrambide G, et al. Among authors: ayuso blanco t.
Neurol Neuroimmunol Neuroinflamm. 2021 Jun 24;8(5):e1024. doi: 10.1212/NXI.0000000000001024. Print 2021 Jul.
Neurol Neuroimmunol Neuroinflamm. 2021.
PMID: 34168057
Free PMC article.
Item in Clipboard
Cite
Cite